Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine injection in refractory or relapsed acute lymphoblastic leukemia (pediatric/young adult)
CTR20171407Phase 2Active
- Sponsor
- Betta Pharmaceuticals
- Start
- Dec 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute lymphoblastic leukemia (ALL), sponsored by Betta Pharmaceuticals. Started Dec 2017; status: active.
02
Drugs
clofarabine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on CTR20171407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171407.